Aescap Venture is a venture capital fund specializing in biotech and pharmaceutical companies, focusing on Series C and Series D funding stages. They help advanced firms bring innovative medicines to market. Notable investments include Affectis Pharmaceuticals. Managed by a skilled team with a strong investment history, Aescap operates under strict financial regulations. The name Aescap derives from Aesculapius, the Roman god of Medicine, reflecting their mission to advance healthcare through strategic investments.
